Purpose:
Evaluate differences in eye care utilization among patients with glaucoma by race and socioeconomic status (SES).
Design:
Retrospective cohort study.
Participants:
Representative 5% sample of Medicare beneficiaries aged > 65 years with continuous part A/B enrollment between January 1, 2014, and July 1, 2014, at least 1 diagnosis code for glaucoma within that period, and a glaucoma diagnosis in the Chronic Conditions Warehouse before January 1, 2014.
Methods:
The following race/ethnicity categories were defined in our cohort: non-Hispanic White, Black/African American, Hispanic, and Asian/Pacific Islander. Low SES was defined as having 2 or more enrollment-based low-income indicators (dual eligibility for Medicare/Medicaid, Part D limited income subsidies, and eligibility for Part A and B State buy-in). Negative binomial regression analyses were carried out to compare relative rate ratios (RRs) of eye care utilization among racial groups stratified by low and non-low SES.
Main Outcome Measures:
Measured from July 1, 2014, to December 31, 2016: eye examinations and eye care-related office visits; eye care-related inpatient and emergency department (ED) encounters; eye care-related nursing home and home-visit encounters; visual field and retinal nerve fiber OCT tests; glaucoma lasers and surgeries.
Results:
Among 78 526 participants with glaucoma, mean age was 79.1 years (standard deviation, 7.9 years), 60.9% were female, 78.4% were non-Hispanic White, and 13.8% met enrollment-based criteria for low-SES. Compared with White beneficiaries, Blacks had lower counts of outpatient visits (RR, 0.92; 95% confidence interval [CI], 0.90-0.93), visual field (VF) tests (RR, 0.92; 95% CI, 0.90-0.94), but more inpatient/ED encounters (RR, 2.42; 95% CI, 1.55-3.78) and surgeries (RR, 1.14; 95% CI, 1.03-1.27). Hispanics had fewer outpatient visits (RR, 0.97; 95% CI, 0.95-0.98) and retinal nerve fiber layer (RNFL) OCT tests (RR, 0.89; 95% CI, 0.86-0.93), but more inpatient/ED encounters (RR, 2.32; 95% CI, 1.18-4.57) and selective laser trabeculoplasty (SLT) (RR, 1.25; 95% CI, 1.11-1.42) versus non-Hispanic Whites. In the non-low SES group, Black versus White disparities persisted in outpatient visits (RR, 0.93; 95% CI, 0.92-0.95), VF (RR, 0.96; 95% CI, 0.94-0.98), RNFL OCT (RR, 0.81; 95% CI, 0.78-0.83), and inpatient/ED encounters (RR, 2.57; 95% CI, 1.55-4.26).
Conclusions:
Disparities were found in eye care utilization among Black and Hispanic patients with glaucoma. These differences persisted among Blacks after stratification by SES, suggesting that systemic racism may be an independent driver in this population.
Citing Articles
Seeing the unseen: uncovering health-related social needs through universal screening at an academic ophthalmology practice.
Mayer N, Cassidy J, Wasser L, Liu P, Williams A
Eye (Lond). 2025; .
PMID: 39955377
DOI: 10.1038/s41433-025-03690-9.
Outcomes of Glaucoma Referrals in Adults Aged 18 to 40 Years.
Frediani T, Yoo K, Cho A, Louie J, Nguyen K, Richter G
JAMA Netw Open. 2025; 8(2):e2457843.
PMID: 39913139
PMC: 11803476.
DOI: 10.1001/jamanetworkopen.2024.57843.
Equitable artificial intelligence for glaucoma screening with fair identity normalization.
Shi M, Luo Y, Tian Y, Shen L, Zebardast N, Eslami M
NPJ Digit Med. 2025; 8(1):46.
PMID: 39833503
PMC: 11747341.
DOI: 10.1038/s41746-025-01432-5.
Infectious keratitis in Western New York: a 10-year review of patient demographics, clinical management, and treatment failure.
Maretz C, Atlas J, Shah S, Sohn M, Wozniak R
Front Ophthalmol (Lausanne). 2024; 4:1469966.
PMID: 39723420
PMC: 11668731.
DOI: 10.3389/fopht.2024.1469966.
Racial and Gender Disparities for Glaucoma Treatment Rates in Upstate New York.
Allison K, Hodges B, Shahid M, Feng C
J Clin Med. 2024; 13(23).
PMID: 39685684
PMC: 11642291.
DOI: 10.3390/jcm13237225.
Socioeconomic and environmental factors associated with glaucoma in an African Ancestry Population: findings from the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study.
Mamidipaka A, Shi A, Lee R, Zhu Y, Chen Y, Rosa I
Eye (Lond). 2024; .
PMID: 39663397
DOI: 10.1038/s41433-024-03470-x.
Big data to guide glaucoma treatment.
Wu J, Lin S, Moghimi S
Taiwan J Ophthalmol. 2024; 14(3):333-339.
PMID: 39430357
PMC: 11488808.
DOI: 10.4103/tjo.TJO-D-23-00068.
Prevalence of Glaucoma Among US Adults in 2022.
Ehrlich J, Burke-Conte Z, Wittenborn J, Saaddine J, Omura J, Friedman D
JAMA Ophthalmol. 2024; 142(11):1046-1053.
PMID: 39418040
PMC: 11581589.
DOI: 10.1001/jamaophthalmol.2024.3884.
Understanding Health Care Disparities Based on Medicare Use for Inflammatory and Infectious Eye Diseases.
Chauhan K, Rosenbaum J
Transl Vis Sci Technol. 2024; 13(8):34.
PMID: 39172483
PMC: 11346134.
DOI: 10.1167/tvst.13.8.34.
Impact of Demographics on Regional Visual Field Loss and Deterioration in Glaucoma.
Pang Y, Tang M, Shi M, Tian Y, Luo Y, Elze T
Transl Vis Sci Technol. 2024; 13(8):25.
PMID: 39136958
PMC: 11323995.
DOI: 10.1167/tvst.13.8.25.
Paving the way while playing catch up: mitochondrial genetics in African ancestry primary open-angle glaucoma.
Kuang G, Salowe R, OBrien J
Front Ophthalmol (Lausanne). 2024; 3():1267119.
PMID: 38983031
PMC: 11182247.
DOI: 10.3389/fopht.2023.1267119.
Social Factors Associated with the Risk of Glaucoma Suspect Conversion to Glaucoma: Analysis of the Nationwide All of Us Program.
Wu J, Halfpenny W, Bu J, Brar M, Weinreb R, Baxter S
Ophthalmol Glaucoma. 2024; 7(6):551-562.
PMID: 38959998
PMC: 11585445.
DOI: 10.1016/j.ogla.2024.06.007.
Risk factors affecting the utilization of eye care services evaluated by the CDC's behavior risk factor surveillance system from 2018 to 2021.
Powers A, Patel D, Deangelis M, Feng C, Allison K
Front Public Health. 2024; 12:1335427.
PMID: 38915755
PMC: 11194383.
DOI: 10.3389/fpubh.2024.1335427.
Features Associated with Visible Lamina Cribrosa Pores in Individuals of African Ancestry with Glaucoma: Primary Open-Angle African Ancestry Glaucoma Genetics (POAAGG) Study.
Jordan J, Daniel E, Chen Y, Salowe R, Zhu Y, Miller-Ellis E
Vision (Basel). 2024; 8(2).
PMID: 38651445
PMC: 11036295.
DOI: 10.3390/vision8020024.
Disparities in Visual Field Testing Frequency Among Subjects With Glaucoma.
Madu C, Lee T, Sohn A, Hu J, Matayev R, Paranjpe V
Transl Vis Sci Technol. 2024; 13(4):2.
PMID: 38564202
PMC: 10996970.
DOI: 10.1167/tvst.13.4.2.
Insights Into Eye Care Accessibility: Geospatial Distribution of Eye Care Providers and Socioeconomic Factors by ZIP Code.
Tran M, Gonzalez V, Mead-Harvey C, Shen J
Transl Vis Sci Technol. 2024; 13(3):21.
PMID: 38530303
PMC: 10981161.
DOI: 10.1167/tvst.13.3.21.
Evaluation of the Observational Associations and Shared Genetics Between Glaucoma With Depression and Anxiety.
Zhang X, Liang Y, Huang Y, Liu S, Li Q, Wang S
Invest Ophthalmol Vis Sci. 2024; 65(3):12.
PMID: 38466289
PMC: 10929750.
DOI: 10.1167/iovs.65.3.12.
Social determinants of health and health disparities in glaucoma: A review.
Acuff K, Wu J, Varkhedi V, Baxter S
Clin Exp Ophthalmol. 2024; 52(3):276-293.
PMID: 38385607
PMC: 11038416.
DOI: 10.1111/ceo.14367.
Stress, Allostatic Load, and Neuroinflammation: Implications for Racial and Socioeconomic Health Disparities in Glaucoma.
McDermott C, Salowe R, Rosa I, OBrien J
Int J Mol Sci. 2024; 25(3.
PMID: 38338933
PMC: 10855412.
DOI: 10.3390/ijms25031653.
Practice Patterns and Sociodemographic Disparities in the Clinical Care of Anatomical Narrow Angles in the United States.
Yoo K, Apolo G, Lung K, Toy B, Xu B
Am J Ophthalmol. 2024; 261:66-75.
PMID: 38218513
PMC: 11031323.
DOI: 10.1016/j.ajo.2024.01.003.